Join more than 40,000 oncology professionals from around the world at the 2022 ASCO Annual Meeting. Stay up to date on new clinical cancer advances in every area of cancer research, gain real-time insights from world-renown...
Read MoreJoin more than 40,000 oncology professionals from around the world at the 2022 ASCO Annual Meeting. Stay up to date on new clinical cancer advances in every area of cancer research, gain real-time insights from world-renown...
Read MoreThe CMSC Annual Meeting provides a variety of credit offerings for attendees. Physician attendees can earn up to 18.0 AMA PRA Category 1 CreditsTM over the course of the meeting. Physician Assistants can earn up to 18.0 AAPA...
Read MoreStrongly Recommended In all conference and meeting rooms, you should wear your mask. Presenters and moderators/panelists can remove their mask when speaking. In standing room spaces, when engaged in extended conversation or are...
Read More
Advancing Advocacy in MS: Access to Affordable, High-Quality Care and Treatments Wednesday, June 1 at 8:00 am Delivering Patient-Centered, Equitable Multiple Sclerosis Care: The Latest Evidence and Real-World Perspectives...
Read More
Focus on MS MAY 2022v2.indd
Read MoreElevated levels of neurofilament light chain (NfL) are a known biomarker for neurodegeneration in conditions such as stroke, dementia, Multiple sclerosis, and Amyotrophic lateral sclerosis. A new study reveals that NfL may also...
Read More
Patients with relapsing multiple sclerosis (RMS) achieved No Evidence of Disease Activity (NEDA)...
Read More
New data from pediatric patients with pulmonary hypertension (PH) found that a majority is...
Read More
High-intensity interval training resulted in a 24% reduction in daily inhaled corticosteroids...
Read More
The randomized COVI-PRONE clinical trial demonstrated no difference in the risk of endotracheal...
Read More
Asymptomatic adults should not be screened for chronic obstructive pulmonary disease (COPD), the...
Read More
Patients with severe, uncontrolled asthma demonstrated overall 2.8-fold higher odds of improved...
Read More
The phase 3 Liberty Asthma VOYAGE trial reported that dupilumab reduced severe asthma exacerbation...
Read More
In a prospective, randomized controlled trial, morbidly obese patients with normal lung function...
Read More
Hydrocortisone treatment in preterm infants, starting on postnatal day 14 to 28, did not result in...
Read More
The international results of the first series of patients indicate that when lung transplantation...
Read More
A post hoc analysis of the SPRINTER trial suggests that the inhaled, interferon-β investigational...
Read More
In patients with uncontrolled moderate-to-severe asthma, the risk of asthmatic exacerbation was...
Read More
